Background In patients with ST-segment elevation myocardial infarction (STEMI),
percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of …

Background Guidelines recommend adjunct glycoprotein IIb/IIIa inhibitors (GPIs) only in
selected patients with acute ST-segment elevation myocardial infarction (STEMI). This study …

Abstract The coronavirus disease 2019 (COVID-19), which is caused by a novel coronavirus
(SARS-COV-2), has compromised health care systems and normal management of patients …

Abstract Background: The COMPLETE (Complete vs Culprit-only Revascularization to Treat
Multi-vessel Disease After Early PCI for STEMI) trial demonstrated that staged nonculprit …

Background: Recent clinical trial data support a pharmacoinvasive strategy as an alternative
to primary percutaneous coronary intervention (pPCI) in ST-segment elevation myocardial …

Objectives To compare treatment and outcomes for patients admitted to hospital with a
primary diagnosis of ST elevation or non-ST elevation myocardial infarction (STEMI or …

Background: Mortality remains high in patients with ST-segment–elevation myocardial
infarction (STEMI) complicated by cardiogenic shock (CS), and early reperfusion has been …

Background: Transradial access (TRA) has emerged as the preferred vascular access site
for coronary angiography and percutaneous coronary intervention. This systematic review …

One of the major missions of the Taiwan Society of Cardiology is to publish practice
guidelines that are suitable for local use in Taiwan. The ultimate purpose is to continuously …

Introduction Multiple national organizations and federal agencies have promoted the
development, implementation, and evaluation of evidence-based guidelines (EBGs) for …